2022-08-16 09:00:00 CEST

2022-08-16 09:00:13 CEST


REGULATED INFORMATION

English
Optomed Oyj - Notice to general meeting

NOTICE OF THE EXTRAORDINARY GENERAL MEETING OF OPTOMED PLC


Optomed Plc         Stock Exchange Release    16 August 2022 at 10.00 Helsinki

NOTICE OF THE EXTRAORDINARY GENERAL MEETING OF OPTOMED PLC

Notice is given to the shareholders of Optomed Plc (“Optomed” or the “Company”)
of the Extraordinary General Meeting (the “General Meeting”) to be held on
Tuesday, 6 September 2022 at 10:00 a.m. (EEST) at Life Science Center
Keilaniemi, Keilaranta 16 B, FI-02150 Espoo, Finland. The reception of persons
who have registered for the meeting and the distribution of voting tickets will
commence at 9:30 a.m. (EEST).

 A. Matters on the agenda of the General Meeting

At the General Meeting, the following matters will be considered:

 1. Opening of the meeting
 2. Calling the meeting to order
 3. Election of persons to scrutinize the minutes and to supervise the counting
of votes
 4. Recording the legality of the meeting
 5. Recording the attendance at the meeting and adoption of the list of votes
 6. Composition of the Board of Directors

The Shareholders' Nomination Board proposes to the General Meeting that Mr. Mars
Duan would be elected as a new member of the Board of Directors in addition to
the current members of the Board of Directors for the term expiring at the end
of the Annual General Meeting 2023.

Mr. Mars Duan is a Vice President with Cenova Capital. Prior to Cenova, Mr. Duan
worked for the Duff & Phelps Securities LLC investment banking team, PwC
corporate finance team and KPMG Shanghai audit team. Mr. Duan is a CFA charter
holder and holds a CPA qualification. He graduated from the University of
Shanghai for Science and Technology with Bachelor's degrees in Engineering and
Accounting.

The annual remuneration payable to Mr. Duan in accordance with the resolution of
the Annual General Meeting held on 10 May 2022 will be paid on a pro rata basis
for the duration of his term.

According to the Articles of Association, Optomed's Board of Directors consists
of a minimum of five (5) and a maximum of eight (8) members. On 10 May 2022, the
Annual General Meeting decided that the number of members of the Board of
Directors during the ongoing term of office is five (5). Following the
resignation of Xisi Guo announced by the Company on 22 July 2022, the number of
Directors will be four (4), and the proposed election would increase the number
of Board members to be five (5) again.

Mr. Duan is independent of the Company and dependent of its significant
shareholder Cenova Capital.

 7. Closing of the meeting

 B. Documents of the General Meeting

This notice, which includes the proposals for resolution on the matter on the
agenda of the General Meeting, is available on Optomed's website at
www.optomed.com/investors/extraordinary-general-meeting-2022. It will also be
available at the General Meeting. A copy of the document will be sent to
shareholders upon request. The minutes of the General Meeting will be available
on the above-mentioned website as from 20 September 2022 at the latest.

 C. Instructions for the participants in the General Meeting

 1. Shareholders registered in the shareholders' register

Each shareholder who is registered in the shareholders' register of the Company
maintained by Euroclear Finland Oy on the record date of the General Meeting, on
25 August 2022, has the right to participate in the General Meeting. A
shareholder whose shares are registered on his/her personal Finnish book-entry
account is registered in the shareholders' register of the Company. Instructions
for holders of nominee-registered shares are set out below under Section C. 2.
“Holders of nominee-registered shares”.

A shareholder who is registered in the shareholders' register of the Company and
who wants to participate in the General Meeting, shall register for the meeting
no later than on 30 August 2022 at 4:00 p.m. (EEST) by giving a prior notice of
participation. The notice must be received by the Company before the end of the
registration period. Registration for the General Meeting starts on 16 August
2022 at 10:00 a.m. (EEST):

 a. through the Company's website at the address
www.optomed.com/investors/extraordinary-general-meeting-2022;

The electronic registration requires strong electronic identification (bank
codes or Mobile ID) for natural persons. For shareholders that are legal
persons, no strong electronic authentication is required. A legal person must,
however, provide its book-entry account number and other required information.
If a legal person uses the electronic Suomi.fi e-authorization, registration
requires a strong electronic authentication of the authorized person by using
bank codes or Mobile ID.

b. by regular mail to the address Euroclear Finland Oy, Yhtiökokous/Optomed Plc,
P.O. Box 1110, FI-00101 Helsinki; or

c. by e-mail to yhtiokokous@euroclear.eu.

In connection with the registration, a shareholder must state his/her name,
personal identification number or business identity code, address, telephone
number and the name of a proxy representative or legal representative and the
personal identification number of the proxy representative or legal
representative. The personal data given to Optomed by shareholders is used only
in connection with the General Meeting and with the processing of related
registrations.

The shareholder, his/her proxy representative or legal representative shall, if
necessary, be able to prove his/her identity and/or right of representation at
the General Meeting.

 2. Holders of nominee-registered shares

A holder of nominee-registered shares has the right to participate in the
General Meeting by virtue of such shares based on which he/she on the record
date of the General Meeting, i.e. on 25 August 2022, would be entitled to be
registered in the shareholders' register of the Company maintained by Euroclear
Finland Oy. The right to participate in the General Meeting requires, in
addition, that the shareholder has, on the basis of such shares, been
temporarily registered in the shareholders' register maintained by Euroclear
Finland Oy at the latest by 1 September 2022 at 10:00 a.m. (EEST). As regards
nominee-registered shares, this constitutes due registration for the General
Meeting.

A holder of nominee-registered shares is advised to request without delay the
necessary instructions regarding the temporary registration in the shareholders'
register of the Company, the issuing of proxy documents and the registration for
the General Meeting from his/her custodian bank. The account management
organization of the custodian bank shall register a holder of the nominee
registered shares, who wants to participate in the General Meeting, into the
temporary shareholders' register of the Company at the latest by the time stated
above.

 3. Proxy representatives and powers of attorney

A shareholder who has registered for the meeting may participate in and exercise
his/her rights at the General Meeting by way of proxy representation.

A proxy representative shall produce a dated proxy document or otherwise in a
reliable manner demonstrate his/her right to represent the shareholder at the
General Meeting. When a shareholder participates in the General Meeting by means
of several proxy representatives, representing the shareholder with shares in
different book-entry accounts, the shares by which each proxy representative
represents the shareholder shall be identified in connection with the
registration for the General Meeting.

Possible proxy documents should be notified in connection with registration, and
they are requested to be delivered completed and signed by mail to Euroclear
Finland Oy, Yhtiökokous/Optomed Plc, P.O. Box 1110, FI-00101 Helsinki, Finland
or by email to yhtiokokous@euroclear.eu at the latest by 30 August 2022 at 4:00
p.m. (EEST), by which time the proxy documents must be received.

Shareholders that are legal persons can also use the electronic Suomi.fi
authorization service instead of a traditional proxy document. In such a case,
the legal person authorizes an assignee nominated by it in the Suomi.fi service
at https://www.suomi.fi/e-authorizations by using the authorization topic
“Representation at the General Meeting”. The assignee must identify him/herself
with strong electronic authentication when registering, after which the
electronic mandate is automatically checked. The strong electronic
authentication works with personal bank codes or Mobile ID. For more
information, see https://www.suomi.fi/e-authorizations and the Company's website
at www.optomed.com/investors/extraordinary-general-meeting-2022.

 4. Advance voting

Shareholders with a Finnish book-entry account may vote in advance on certain
matters on the agenda of the General Meeting during the period from 16 August
2022 at 10:00 a.m. (EEST) until 30 August 2022 at 4:00 p.m. (EEST).

Unless a shareholder who has voted in advance is also present in the General
Meeting in person or by proxy representation, it is not possible for him / her
to pose questions, to request a vote at the General Meeting or to vote on a
possible counterproposal made at the General Meeting.

Advance voting can take place:

 a. through the Company's website at www.optomed.com/investors/extraordinary
-general-meeting-2022; or

Voting in advance requires strong electronic identification (bank codes or
Mobile ID) for natural persons. For shareholders that are legal persons, no
strong electronic authentication is required. A legal person must, however,
provide its book-entry account number and other required information. If a legal
person uses the electronic Suomi.fi e-authorization, registration requires a
strong electronic authentication of the authorized person by using bank codes or
Mobile ID.

 b. by regular mail or email.

A shareholder may deliver an advance voting form available on the Company's
website or corresponding information by mail to Euroclear Finland Oy to the
address Euroclear Finland Oy, Yhtiökokous/Optomed Plc, P.O. Box 1110, FI-00101
Helsinki or by email to yhtiokokous@euroclear.eu.

If a shareholder participates in the General Meeting by submitting advance votes
by mail or e-mail to Euroclear Finland Oy, the submission of votes before the
due date of the registration period and advance voting constitutes due
registration for the General Meeting provided that the aforementioned
information required for the registration mentioned above in Section C. 1. is
received before the end of the advance voting period.

Instructions concerning the voting can be found on the Company's website at
www.optomed.com/investors/extraordinary-general-meeting-2022.

 5. Other instructions and information

Pursuant to Chapter 5 Section 25 of the Finnish Companies Act, a shareholder who
is present at the General Meeting has the right to pose questions with respect
to the matters to be considered at the General Meeting.

On the date of this notice of the General Meeting, 16 August 2022, the total
number of shares and votes in Optomed Plc is 15,400,997. Changes in the share
ownership following the record date of the General Meeting do not have an impact
on the right to participate in the General Meeting nor on the number of votes of
the shareholder.

In Espoo, 16 August 2022

OPTOMED PLC

The Board of Directors